Background: The effectiveness of allergen immunotherapy (AIT) in seasonal allergic rhinitis (AR) depends on the definition of pollen exposure intensity or time period.
| BACKG ROU N D
Allergic rhinitis (AR) is a significant health problem due to the symptom load as well as its impact to the quality of life of the affected part of the population. It also implies a high economic burden. [1] [2] [3] The cause of the disease is an immunological abnormality leading to IgEmediated hypersensitivity reactions resulting from the exposure to allergens. 3 The treatment of choice for dealing with the causes of AR rather than its symptoms is allergen immunotherapy (AIT) that aims to promote tolerance of the immune system toward allergens. [4] [5] [6] [7] AIT has been shown to be highly efficacious in the treatment of allergic diseases such as allergic rhinoconjunctivitis with or without allergic asthma, 8 including improvement of symptoms, quality of life, longterm symptom control and preventive potential. [9] [10] [11] However, clinical effects in clinical trials demonstrated that pollen exposure has a direct influence on the level of AIT efficacy measured. 12 Overall, the definition of pollen season (PS) and peak pollen periods (PPP) should follow a harmonized application of pollen exposure criteria, taking into account biogeographical differences that may reflect local climate and phenology. 13, 14 Such a definition has been proposed in a recently published Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI), 15 summarized for birch (Betula) and grass (Poaceae) in Table 1 . In the framework of this initiative, we have recently verified the robustness of these definitions for grass pollen in Germany, making use of 5-year measurements from up to 40 monitoring stations in the country. 16 Moreover, the correlation between birch and grass pollen concentrations and actual symptom loads, as reported by users of patient's hay-fever diary (PHD), 17 during the defined birch and grass pollen seasons, has been demonstrated for the Berlin-Brandenburg region in Germany for three consecutive years: 2014, 2015, and 2016. 18 Following the previous study in Germany, 18 This report aims to analyze whether birch and grass pollen season and peak pollen periods, as defined by the EAACI, can be identified in different regions in Europe and, more importantly, whether these definitions reflect the development of seasonal symptoms.
| MATERIAL S AND ME THODS
The selection of these European regions considered the availability of sufficient pollen data as well as symptom data via the PHD. The pollen types that were included in the analysis were birch (Betula) and grass (Poaceae) in the years of 2014, 2015, and 2016. We therefore considered one region per country: the Pannonian lowlands region of Austria, the southern region of Finland, and the Rhone-Alps region of France. We used data from a total of twenty-three pollen monitoring stations ( Figure 1 and Table S1 ).
Data of daily AR related to symptom levels and concomitant medication use are reported on a voluntary, regional, and anonymized basis through a web-based Pollen App, which includes the PHD (https ://polle ndiary.com). The number of symptom reports was highly variable: The mean yearly number of PHD users (ie, a 12-month period statistic, rounded to the closest integer) reporting symptoms for the Austrian, Finnish, and the French region was 138, 37, and 17 for year 2014; 118, 21, and 18 for year 2015; and 106, 14, and 16 for year 2016.
For this study, we have considered the daily average pollen concentration (in pollen grains/m 3 ) from all monitoring stations for birch and grass. Hereafter, the PHD data were processed in order to calculate the Total Nasal Symptom and Medication Score (TNSMS).
The details of score calculation have been reported before, 18 and the calculation is also based on prior studies. 19, 20 Reported symptoms are influenced by concomitant medication. 21, 22 However, different medication classes have different effects in improving allergic symptoms of patients. For this reason, we adopted a Weighted Nasal Medication use Score (WNMS) as reported in detail. 18, 20 All available data were averaged per day in order to represent the mean daily pollen as well as the mean TNSMS levels in all studied regions. To provide a data overview, basic descriptive statistics for the 3 years of study have been presented in Supporting information related to the main daily data (Table S2 ) and pollen season (Table S3 ).
A classic approach for data analysis was employed to investigate the correlations between daily symptom and pollen data during the pollen season, following both a parametric (Pearson's r) and a non-parametric (Spearman's ρ) estimation. The correlation coefficients and the associated p-values, indicating statistical significance between the TNSMS and the pollen concentrations (for birch and grass), were calculated for the PS period defined with the EAACI definitions for each pollen type and year. Details can be found in the Supporting information (Appendix S1 : correlation calculations).
We also used a graphical representation of symptom data together with (a) pollen concentrations, (b) PS start and end as well as (c) PPP, to visually represent the temporal variation of symptoms as well as of pollen data for all areas and years of study and to further investigate their relationships (Appendix S1 S2: graphical representation and investigation of data).
| RE SULTS
The basic descriptive statistics for the three countries are reported in Table S2a -c. In addition, the pollen season and peak pollen period start and end for both pollen types were calculated based on the EAACI definitions ( 15 , Table S3a ,b).
Moreover, the correlation coefficients between the TNSMS and the pollen concentrations (for birch and grass) were calculated for the period characterized from the PS start and end per pollen type and year (Table S4a- 
Birch
Start: 1st day of 5 d (out of 7 consecutive days), each of these 5 d with ≥10 pollen/m 3 and with a sum of these 5 d of ≥100 pollen/m 3 End: Last day of series of 5 d (out of 7 consecutive days) with ≥10 pollen/m 3 and with a sum of these 
Correlation of pollen concentrations and reported symptoms
for the PS-start to PS-end period provide clear evidence concerning the validity of the EAACI definitions. Both correlation coefficients appeared high and were statistically significant in most of the cases (Table S4a- 
| D ISCUSS I ON
The effect sizes of AIT as demonstrated in trials for AR depend on the validity of definitions of, that is, the pollen season (PS) start and end as well as the peak pollen period (PPP). 13, 15 The pol- In the frame of this analysis in three European regions and our recently published report of German data, 18 we could confirm that the EAACI criteria lead to the identification of PS for all areas in subsequent years for birch and grass pollen. In addition, we were able to demonstrate that (a) the TNSMS is correlated with birch and grass pollen levels within the respective pollen seasons (with the exception of grass pollen in 2016 for Finland and France, for which correlation coefficients are not statistically significant;
for the latter, however, the symptoms of users in the beginning of September in France may be influenced by, e.g., local ragweed (Ambrosia) pollen) and (b) the maximum symptom levels occurred mostly within the PPP following the EAACI criteria. 15 This current calculation also underlines the feasibility of the criteria to serve as the basis for clinical trials in the future such as confirmatory F I G U R E 2 Temporal variation of the TNSMS, the number of PHD users, and the birch and grass pollen concentrations for 2014 (mean daily values, Pannonian lowlands region of Austria). The PS per pollen type is marked with arrows with a textual label. The multiple PPP startsends are denoted with double arrows. The horizontal axis reports month start. The vertical axis reports the normalized (between zero and one) values of the number of PHD users, the grass, and birch pollen daily concentrations and the TNSMS field-based trials in AIT and for management of AR patients in the clinical routine. Based on our findings, the EAACI definitions for birch and grass are scientifically justified and sound for practical use. However, additional analyses on further European regions on a sufficient number of PHD users may also be required to account for local conditions and deviations.
Since PHD does not collect pollen-specific symptoms, it is obvious that the symptom levels are high not only within the pollen season of aforementioned pollen types, but also apart from it, thus indicating the influence of additional parameters that affect the scores reported by PHD users. First, the flight of, for example, the birch pollen in many regions is preceded by the flight of hazel This observation highlights the regional differences in population sensitivity to pollen concentrations: Tolerance to birch pollen concentrations in Finland is much higher than in Central Europe. The current season definition does not account for this variability.
One limitation of our analysis is the limited number of experienced sites involved as well as the limited amount of datasets from patients who had to fulfill (pre-specified) inclusion criteria for reporting. However, the high correlation of symptom levels reported by PHD users with pollen concentration levels in our current analysis (as well as in our recent report 18 Further work of the Task Force group will aim to reproduce this finding in other European regions.
| CON CLUS IONS
The for a variety of plant species. To confirm these definitions, we have analyzed reported symptom and used medication data from the patient's hay-fever diary (PHD) and birch and grass pollen concentrations in Germany in a previous research and have found a positive and significant correlation and therefore a confirmation of the EAACI criteria on the regional level. In the subsequent analysis reported here, we have further investigated three additional European regions (in Austria, in Finland, and in France) again for three subsequent years.
In conclusion, we identified the pollen season characteristics and we also confirmed a sound correlation between TNSMS and birch and grass pollen season start, end, and peak pollen period in all three European regions. Based on the current analysis and the previous research, the validity of the EAACI definitions on birch and grass pollen season and for a variety of geographical locations is consistently confirmed. Their clinical use in future clinical trials on AIT as well as in daily clinical routine for optimal patient care is recommended.
